Best peptides for Metabolic

GLP-1 Agonist | Type 2 Diabetes and Obesity

Semaglutide is a synthetic analog of glucagon-like peptide-1 (GLP-1), a hormone involved in glucose metabolism and appetite regulation. As a GLP-1 receptor agonist, semaglutide enhances insulin secretion in response to elevated blood glucose levels, suppresses glucagon secretion, and slows gastric emptying, leading to improved glycemic control. Additionally, it promotes satiety, contributing to weight loss, which has made it a focus of research for managing both type 2 diabetes and obesity.

Mitochondrial protection | Heart and neuro health

SS-31, also known as Elamipretide, is a peptide that has garnered attention for its potential role in mitochondrial protection and its implications in various health conditions, particularly those involving oxidative stress and mitochondrial dysfunction.

Metabolic | Energy production and cellular repair

NAD+ (Nicotinamide adenine dinucleotide) is a crucial coenzyme involved in various metabolic processes, including energy production and cellular repair mechanisms. Recent research highlights its potential roles in protecting against oxidative stress and enhancing therapeutic efficacy in certain cancer treatments.

Modulation of endothelial function | Vascular health

PE 22-28 is a peptide that has attracted interest for its potential roles in vascular health and metabolic conditions, particularly in the context of gestational diabetes and placental function. The peptide is derived from the sequence of the human protein, and its mechanism of action is thought to involve modulation of endothelial function and inflammatory responses, which are critical in maintaining vascular integrity and metabolic homeostasis.

ERR Agonist | Metabolic Modulator

Synthetic Pan-ERR Agonist | Exercise Mimetic & Metabolic Modulator

Stimulates red blood cell production | Anemia treatment

Erythropoietin (EPO) is a glycoprotein hormone that stimulates red blood cell production in bone marrow, used clinically for anemia and studied in hematology and metabolic research.

Vasopressin | Water balance regulation

Research peptide discovered via AI researcher. peptide-based therapeutic

Metabolic regulation | Male fertility

MOTS-C is a mitochondrial-derived peptide that has garnered attention for its potential roles in metabolic regulation and cellular stress responses. Emerging research suggests it may have implications in various health conditions, including cardiovascular diseases and placental function.

GLP-1/glucagon agonist | Weight loss and diabetes

Mazdutide (IBI362) is an investigational dual GLP-1/glucagon receptor agonist studied for weight loss and type 2 diabetes, combining appetite suppression with increased energy expenditure.

GLP-1 Agonist | Type 2 Diabetes and Obesity

Orforglipron (LY-3502970) is an investigational oral small-molecule GLP-1 receptor agonist studied for type 2 diabetes and obesity, offering pill-based dosing without injection.

GLP-1/Glucagon Agonist | Weight Loss & Diabetes

Survodutide (BI 456906) is a novel dual agonist targeting both the glucagon-like peptide-1 (GLP-1) and glucagon receptors. This peptide is under investigation primarily for its potential in treating obesity and metabolic dysfunction-associated steatotic liver disease (MASLD). The dual action of Survodutide aims to enhance weight loss while also improving glycemic control, which is particularly relevant in the context of type 2 diabetes and associated metabolic disorders.

GIP & GLP-1 Agonist | Type 2 Diabetes Management

Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that has been investigated for its potential in managing type 2 diabetes and obesity. Its unique mechanism of action aims to enhance glycemic control and promote weight loss.

Fatty acid transport | Metabolic health

L-Carnitine (levocarnitine) is an amino acid derivative that shuttles long-chain fatty acids into mitochondria for energy production, studied for metabolic, cardiovascular, and exercise performance applications.

GnRH Agonist | Prostate cancer treatment

Research peptide discovered via AI researcher. peptide-based therapeutic

Triple Agonist | Weight Loss & Diabetes

Triple GLP-1/GIP/Glucagon Agonist | Weight Loss & Diabetes

GLP-1 Agonist | Type 2 Diabetes Management

Research peptide discovered via AI researcher. peptide-based therapeutic

Inhibition | Weight loss and metabolic regulation

Tesofensine is a synthetic compound that was initially developed as an antidepressant but has garnered interest for its potential role in weight loss and metabolic regulation. Its mechanism of action involves the inhibition of the reuptake of neurotransmitters such as serotonin, norepinephrine, and dopamine, which may lead to reduced appetite and increased energy expenditure. By modulating these neurotransmitters, tesofensine may help in regulating energy balance and body weight.

GLP-1 Agonist | Type 2 Diabetes Management

Liraglutide is a synthetic analog of human glucagon-like peptide-1 (GLP-1), a hormone that plays a crucial role in glucose metabolism and appetite regulation. It acts as a GLP-1 receptor agonist, stimulating insulin secretion in response to elevated blood glucose levels while suppressing glucagon release, which helps lower blood sugar levels. Additionally, liraglutide slows gastric emptying and promotes satiety, contributing to weight loss in individuals with obesity or type 2 diabetes.

Mitochondrial function | Longevity

Humanin is a mitochondria-derived peptide that plays a significant role in cellular health and longevity. It is encoded by the mitochondrial genome and has been implicated in various cellular processes, including the regulation of apoptosis, inflammation, and oxidative stress. Humanin has been shown to exert protective effects in models of neurodegenerative diseases and metabolic disorders, suggesting its potential as a therapeutic agent in these conditions.

Amylin receptor agonist | Obesity treatment

Eloralintide is a selective amylin receptor agonist that has been investigated for its potential role in the treatment of obesity. The mechanism of action involves the activation of amylin receptors, which are implicated in regulating appetite and glucose metabolism. By mimicking the effects of the naturally occurring hormone amylin, Eloralintide may help reduce food intake and promote weight loss through central nervous system pathways that influence satiety and energy expenditure.

GLP-1 Agonist | Type 2 Diabetes Management

Research peptide discovered via AI researcher. peptide-based therapeutic

GLP-1 Agonist | Type 2 Diabetes Management

Exenatide is a synthetic peptide that mimics the action of glucagon-like peptide-1 (GLP-1), a hormone involved in glucose metabolism. It functions primarily as a GLP-1 receptor agonist, promoting insulin secretion in response to elevated blood glucose levels, inhibiting glucagon release, and slowing gastric emptying. These mechanisms contribute to improved glycemic control in patients with type 2 diabetes and may also aid in weight management due to its appetite-suppressing effects.

Amylin analog | Obesity and type 2 diabetes

Cagrilintide (AM833) is a long-acting amylin analog investigated for once-weekly subcutaneous use in obesity and type 2 diabetes, most notably combined with semaglutide as CagriSema.

GnRH Antagonist | Prostate cancer treatment

Degarelix is a synthetic peptide that functions as a gonadotropin-releasing hormone (GnRH) antagonist. By competitively inhibiting GnRH receptors in the pituitary gland, degarelix reduces the secretion of luteinizing hormone (LH) and follicle-stimulating hormone (FSH), leading to decreased testosterone production in the testes. This mechanism is particularly beneficial in the treatment of hormone-sensitive conditions such as prostate cancer, where testosterone can promote tumor growth.

MC4R Agonist | Weight management in genetic obesity

Research peptide discovered via AI researcher. peptide-based therapeutic

Modulating appetite | Metabolic disorders

Research peptide discovered via AI researcher. research peptide

NNMT Inhibition | Weight management

Research-peptide often discussed for body recomposition: weight-loss–focused with muscle preservation, cholesterol and inflammation effects.

Insulin signaling | Metabolic health

Research peptide discovered via AI researcher. research peptide

GLP-1 Agonist | Type 2 Diabetes Management

Albiglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that was developed for the treatment of type 2 diabetes mellitus (T2DM). It functions by mimicking the action of the endogenous GLP-1 hormone, which is involved in glucose metabolism. Albiglutide enhances insulin secretion in response to elevated blood glucose levels, suppresses glucagon secretion, slows gastric emptying, and promotes satiety, thereby contributing to improved glycemic control and weight management.

GHRH analog | Reduces visceral fat in HIV lipodystrophy

Tesamorelin is a synthetic peptide that acts as a growth hormone-releasing hormone (GHRH) analog. It is primarily investigated for its potential to reduce visceral fat in individuals with HIV-associated lipodystrophy, a condition characterized by abnormal fat distribution often exacerbated by antiretroviral therapy. Tesamorelin stimulates the release of endogenous growth hormone, which in turn promotes lipolysis and reduces visceral adipose tissue (VAT) accumulation.

Lipolysis | Fat loss

A GH-fragment–derived peptide primarily discussed for fat loss and body-composition change, sometimes with cartilage and joint-repair context.

Protonophore uncoupler | Metabolic dysfunction

BAM-15 is a mitochondrial protonophore uncoupler studied preclinically for obesity, insulin resistance, and metabolic dysfunction by increasing energy expenditure without raising heart rate.

Vasopressin analog | Fluid balance regulation

Research peptide discovered via AI researcher. peptide-based therapeutic

Pro-apoptotic | Obesity

Adipotide (Prohibitin-TP01) is an experimental peptidomimetic that targets prohibitin on white adipose vasculature to trigger fat-supply regression, studied preclinically for obesity.

AMPK activator | Metabolic efficiency

AICAR (Acadesine) is a small-molecule compound that acts as an activator of AMP-activated protein kinase (AMPK), a key regulator of cellular energy homeostasis. By mimicking AMP, AICAR promotes a shift in cellular metabolism towards energy-producing pathways, thus enhancing metabolic efficiency. The activation of AMPK by AICAR has been linked to various physiological effects, including improved endurance, metabolic adaptation, and cardioprotective properties.

Mitochondrial stabilization | Mitochondrial dysfunction

Research peptide discovered via AI researcher. peptide-based therapeutic

Glucose regulation | Diabetes management

Research peptide discovered via AI researcher. peptide-based therapeutic

Bioregulator | Pancreatic endocrine support

Pancragen (KEDW) is a synthetic tetrapeptide bioregulator studied for pancreatic endocrine support, glucose-insulin modulation, and longevity applications in preclinical and small human studies.

Stimulates GLP-1 secretion | Appetite regulation

GLP-1 blends refer to combinations of glucagon-like peptide-1 (GLP-1) analogs or related compounds that may enhance the secretion of this hormone, which plays a critical role in glucose metabolism and appetite regulation. Recent research has explored various natural extracts and dietary components that may influence GLP-1 secretion and its physiological effects.

Gene expression modulation | Liver support

Ovagen (EDL) is a Khavinson-family tripeptide bioregulator researched for liver and gastrointestinal tissue support, proposed to act via gene-expression modulation in hepatocytes and enterocytes.

Receptor Interaction | Metabolic Regulation

Research peptide discovered via AI researcher. research peptide

GLP-1 Activation | Metabolic Regulation

Research peptide discovered via AI researcher. peptide-based therapeutic

Lipid metabolism | Fat loss

HGH Fragment 176-191, a peptide derived from the C-terminus of human growth hormone (HGH), has been primarily researched for its potential effects on fat loss and metabolic regulation. This peptide is believed to mimic some of the metabolic effects of HGH without the associated growth-promoting side effects. The mechanism of action is thought to involve the modulation of lipid metabolism and glucose uptake in adipocytes, which may contribute to its fat loss properties.

GnRH Agonist | Hormone regulation

Research peptide discovered via AI researcher. peptide analogue

GLP-1 Agonist | Type 2 Diabetes Management

Research peptide discovered via AI researcher. research peptide

GH stimulation | Growth hormone deficiency

Tesamorelin + Ipamorelin GH Secretagogue Blend

Stimulates GH release | Potential metabolic benefits

GH secretagogue blends are formulations designed to stimulate the secretion of growth hormone (GH) from the pituitary gland. These blends typically consist of various peptides and compounds that may enhance GH release, potentially influencing growth, metabolism, and overall health.

Growth Hormone Fragment | Fat Loss Peptide

HGH Fragment 176-191 is a synthetic C-terminal fragment of human growth hormone studied for its lipolytic (fat-burning) effects without the growth-promoting actions of full GH.

Four-Peptide Regenerative Blend

KLOW is a four-peptide compounded blend (typically KPV, LL-37, GHK, and Wolverine-style healing peptides) studied informally for combined regenerative and metabolic effects.